All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

17

Reset

17 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • PF-08634404SSGJ-707Phase 312 trials

    Pfizer · Non-Small Cell Lung Cancer, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung (NSCLC)

  • PD-1 inhibitorPhase 38 trials

    BioAtla, Inc. · Advanced Solid Tumors, Gastric or Gastroesophageal Junction Adenocarcinoma, NSCLC (Advanced Non-small Cell Lung Cancer)

  • Tegafur-gimeracil-oteracil potassiumS-1, tegafurPhase 38 trials

    Ono Pharmaceutical Co., Ltd. · Gastric Cancer, Esophageal Cancer, Resectable Gastric/Gastroesophageal Junction Adenocarcinoma

  • HEC585Phase 33 trials

    Sunshine Lake Pharma Co., Ltd. · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF), Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)

  • ClifutinibHEC73543Phase 32 trials

    Sunshine Lake Pharma Co., Ltd. · Leukemia, Acute Myeloid (AML), Acute Myeloid Leukemia, Adult

  • LerotinibZ650Phase 31 trial

    Sunshine Lake Pharma Co., Ltd. · Esophageal Cancer

  • ZX-7101APhase 31 trial

    Nanjing Zenshine Pharmaceuticals · Respiratory Viral Infection

  • SSGJ-706Phase 23 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)

  • WSD0922-FUWSD0922Phase 23 trials

    Wayshine Biopharm, Inc. · Non Small Cell Lung Cancer (NSCLC), EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • SPGL008Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · NMIBC, Non Small Cell Lung Cancer

  • SSGJ-612HER2-targeted antibodyPhase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced (Unresectable) or Metastatic Solid Tumors, Metastatic Breast Cancer

  • SSGJ-705Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Locally Advanced, Recurrent or Metastatic Malignancies, Locally Advanced (Unresectable) or Metastatic Solid Tumors

  • SSS17Phase 22 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee

  • HEC53856Phase 21 trial

    Sunshine Lake Pharma Co., Ltd. · Chemotherapy-induced Anemia, Non-Myeloid Malignancy

  • SOA101Phase 21 trial

    Shine-On Biomedical Co., Ltd. · Solid Tumors

  • SSGJ-613Phase 21 trial

    Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · Gout Arthritis

  • SSS06Phase 21 trial

    Shenyang Sunshine Pharmaceutical Co., LTD. · Chemotherapy-induced Anemia, Non-myeloid Malignancies

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.